Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.27B |
| 2 |
Microsoft
MSFT
|
+$452M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$427M |
| 4 |
RTX Corp
RTX
|
+$341M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$333M |
Top Sells
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
+$268M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$128M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| 1 | Technology | 13.84% |
| 2 | Financials | 11.67% |
| 3 | Healthcare | 11.33% |
| 4 | Consumer Discretionary | 10.16% |
| 5 | Communication Services | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAM
2701
Adamas Trust, Inc. Common Stock
ADAM
$644M
| $158K | ﹤0.01% |
6,442
-21,142
| -77% | -$519K |
|
2702
Cytokinetics
CYTK
$6.12B
| $157K | ﹤0.01% |
19,297
+3,794
| +24% | +$30.9K |
|
2703
MacroGenics
MGNX
$100M
| $157K | ﹤0.01% |
8,282
+7,253
| +705% | +$137K |
|
|
AKAO
2704
DELISTED
Achaogen, Inc.
AKAO
| $157K | ﹤0.01% |
14,593
-16,809
| -54% | -$181K |
|
|
TCF
2705
DELISTED
TCF Financial Corporation
TCF
| $157K | ﹤0.01% |
7,620
-18,292
| -71% | -$377K |
|
2706
Telefônica Brasil
VIV
$20B
| $156K | ﹤0.01% |
10,550
+10,549
| +1,054,900% | +$156K |
|
|
ENZ
2707
DELISTED
Enzo Biochem, Inc.
ENZ
| $156K | ﹤0.01% |
19,129
+972
| +5% | +$7.93K |
|
|
CRAY
2708
DELISTED
Cray, Inc.
CRAY
| $156K | ﹤0.01% |
6,439
+5,433
| +540% | +$132K |
|
|
ICON
2709
DELISTED
Iconix Brand Group, Inc.
ICON
| $156K | ﹤0.01% |
12,123
+11,547
| +2,005% | +$149K |
|
2710
BOK Financial
BOKF
$7.06B
| $154K | ﹤0.01% |
1,667
+1,307
| +363% | +$121K |
|
2711
Turning Point Brands
TPB
$1.84B
| $154K | ﹤0.01% |
7,301
+400
| +6% | +$8.44K |
|
|
FPRX
2712
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $154K | ﹤0.01% |
7,033
-3,082
| -30% | -$67.5K |
|
|
ALDR
2713
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $154K | ﹤0.01% |
13,407
-135,249
| -91% | -$1.55M |
|
2714
ProShares Ultra Silver
AGQ
$897M
| $153K | ﹤0.01% |
4,524
+4,343
| +2,399% | +$147K |
|
2715
ATN International
ATNI
$238M
| $153K | ﹤0.01% |
2,769
-1,845
| -40% | -$102K |
|
2716
ProShares Short 20+ Year Treasury ETF
TBF
$69.1M
| $153K | ﹤0.01% |
7,000
| – | – |
|
2717
HCI Group
HCI
$2.34B
| $152K | ﹤0.01% |
5,105
+2,918
| +133% | +$86.9K |
|
2718
iShares Expanded Tech Sector ETF
IGM
$8.98B
| $152K | ﹤0.01% |
5,400
| – | – |
|
|
HSKA
2719
DELISTED
Heska Corp
HSKA
| $152K | ﹤0.01% |
1,894
+364
| +24% | +$29.2K |
|
2720
AngioDynamics
ANGO
$433M
| $151K | ﹤0.01% |
9,084
+4,084
| +82% | +$67.9K |
|
2721
Pathward Financial
CASH
$1.72B
| $151K | ﹤0.01% |
4,863
-29,214
| -86% | -$907K |
|
2722
Evogene
EVGN
$11.1M
| $151K | ﹤0.01% |
4,933
| – | – |
|
2723
ProShares Ultra Financials
UYG
$885M
| $151K | ﹤0.01% |
3,540
+1,425
| +67% | +$60.8K |
|
|
SJR
2724
DELISTED
Shaw Communications Inc.
SJR
| $151K | ﹤0.01% |
6,598
-36,564
| -85% | -$837K |
|
2725
HealthStream
HSTM
$855M
| $150K | ﹤0.01% |
6,486
-164
| -2% | -$3.79K |
|